Portfolio Update

BLACKROCK GREATER EUROPE INVESTMENT TRUST plc All information is at 31 October 2014 and unaudited. Performance at month end with net income reinvested One Three One Three Launch Month Months Year Years (20 Sep 04) Net asset value* (undiluted) -0.5% 0.3% -4.2% 41.8% 182.6% Net asset value* (diluted) -0.5% 0.3% -3.1% 41.9% 182.8% Share price -0.2% 0.0% -6.3% 34.3% 170.2% FTSE World Europe ex UK -1.4% 0.0% -0.8% 39.8% 130.5% Sources: BlackRock and Datastream At month end Net asset value (capital only): 232.50p Net asset value (including income): 232.88p Net asset value (capital only)*: 232.50p Net asset value (including income)*: 232.88p Share price: 221.25p Discount to NAV (including income): 5.0% Discount to NAV (including income)*: 5.0% Subscription share price: 10.13p Net gearing: 0.2% Net yield**: 2.1% Total assets (including income): £253.4m Ordinary shares in issue***: 108,828,058 Subscription shares: 20,647,848 Ongoing charges****: 0.94% * Diluted for subscription shares and treasury shares. ** Based on an interim dividend of 1.5p per share and final dividend of 3.2p per share for the year ended 31 August 2014. *** Excluding 5,429,676 shares held in treasury. **** Calculated as a percentage of average net assets and using expenses, excluding performance fees and interest costs, after relief of taxation for the year ended 31 August 2014. Sector Analysis Total Assets (%) Country Analysis Total Assets (%) Financials 32.1 Switzerland 19.2 Industrials 16.1 France 18.0 Health Care 13.5 Germany 15.8 Consumer Goods 7.7 Netherlands 9.0 Consumer Services 7.3 Italy 8.8 Basic Materials 6.7 Sweden 6.7 Oil & Gas 5.0 Denmark 5.0 Technology 4.9 Ireland 4.5 Utilities 3.9 Russia 3.7 Telecommunications 3.0 Turkey 2.8 Net current liabilities (0.2) Belgium 2.5 ----- Finland 2.4 100.0 Portugal 0.7 ===== Hungary 0.7 Spain 0.4 Net current liabilities (0.2) ----- 100.0 ===== Ten Largest Equity Investments Company Country % of Total Assets Roche Switzerland 6.7 Novo-Nordisk Denmark 5.0 Bayer Germany 4.9 Novartis Switzerland 3.9 GDF Suez France 3.9 Zurich Insurance Switzerland 3.6 Schneider Electric France 3.1 Total France 3.1 Deutsche Telekom Germany 3.0 Ryanair Ireland 2.7 Commenting on the markets, Vincent Devlin, representing the Investment Manager noted: During the month, the Company's NAV fell by 0.5% and the share price fell by 0.2%. For reference, the FTSE World Europe ex UK Index fell 1.4% during the same period (all returns in sterling terms with income reinvested). European equity markets fell in October. Unlike in recent months, large caps underperformed small and mid-caps. European equity markets performed worse than other developed markets: the US gained 3.2% (Euro terms) and World Equities gained 1.5% (Euro terms). October also proved to be a volatile month: the market fell 9.6% by 16 October before recovering later in the month. At the beginning of the month, a disappointing European Central Bank (ECB) council meeting (no significant policy action announced) combined with further falls in the oil price initially caused concern and business confidence indicators in the Eurozone were worse than expected. Later in the month, however, announcements in the third quarter reporting season for companies proved positive. On a sector basis, oil & gas underperformed on the back of a weakening oil price. Stock selection drove performance during October, while the Company's sector allocation detracted from returns. A lower weight in consumer goods when compared with the market hindered returns overall. Stock selection in health care was especially profitable. A position in Fresenius, the German based health care group, supported returns as the group reported earnings that were better than expected for the third quarter. In addition, avoiding holding Sanofi, which reported poorer than expected Q3 results and as the company has suffered from rumored changes to their CEO, contributed strongly to returns. In industrials, a position in Geberit, a Swiss manufacturing company, rallied from mid-month on the news of their acquisition of Sanitec, which will bolster their growth potential and visibility. Finally, two holdings in Turkish banks performed well during October. Holdings in Italian companies proved less successful. ENI fell on the back of the underperformance of the oil & gas sector. In financials, Italian asset management group Anima Holding and Banca Popolare di Milano also detracted. The share price for Banca Popolare di Milano was volatile during the month and has fallen off in the wake of the AQR, which highlighted a capital deficiency at the end of 2013. However, adjusted for capital raised in 2014, the bank was deemed to hold sufficient levels and remains attractive in the long term. On a positive note, not holding KBC contributed to returns. At the end of the month, the Company had higher exposure to health care, financials, technology and consumer services, and less exposure to consumer goods, basic materials, telecoms and utilities. Outlook The European economic recovery has weakened in recent months, despite an increasingly aggressive ECB in terms of monetary stimulus. However, we remain of the view that Europe is not heading towards a triple-dip recession; we believe that we are in a period of gentle, albeit muted European recovery (implied by composite PMIs remaining in expansion territory), with economic momentum held back by the structural reforms and ongoing fiscal tightening. Recent policy measures at the ECB are coming into force throughout the fourth quarter and latest evidence suggests that the transmission mechanisms into the economy are improving, with ECB lending surveys continuing to show an increase in demand for credit from both corporates and households. With the AQR and stress tests on Eurozone banks now complete, the market has clarity on future bank capital needs, which should allow banks to fully exploit the ECB liquidity measures (TLTRO, ABS) from now on. 13 November 2014 ENDS Latest information is available by typing www.brgeplc.co.ukon the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). Neither the contents of the Manager's website nor the contents of any website accessible from hyperlinks on the Manager's website (or any other website) is incorporated into, or forms part of, this announcement.
UK 100

Latest directors dealings